Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Ewing sarcoma

Ewing sarcoma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ewing sarcoma

7 trials tracked for Ewing sarcoma.

7Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 6 Phase 1 1
  1. Phase 2 Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) Completed
  2. Phase 2 A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors Completed
  3. Phase 2 Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors Completed
  4. Phase 2 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) Completed
  5. Phase 2 Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Completed
  6. Phase 2 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Completed
Show 1 more trials
  1. Phase 1 Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Primary pulmonary Ewing sarcoma should be considered in non-smoking patients with hemoptysis or back pain
Oncology Sys. Review
Primary pulmonary Ewing sarcoma should be considered in non-smoking patients with hemoptysis or back pain New cases help identify rare lung cancer in specific patients
This case report and literature review describes 2 cases of primary pulmonary Ewing sarcoma (PES). The authors argue that PES should be incl…
Doctors identified a rare type of lung cancer in two patients, highlighting how different symptoms can point toward this specific diagnosis.
Frontiers Aug 22, 2026